Community

Advertising Opportunities

 Biotechnology Europe Programs

 Resources

Biotechnology Europe Community

Feedback

Contact

Biotechnology Europe Advantages

Advertising Opportunities on Biotechnology Europe

Sponsorship Opportunities on Biotechnology Europe

 

Post a Job on Biotechnology Europe

Post a Company Profile on Biotechnology Europe

Post a News on Biotechnology Europe

Post an Event on Biotechnology Europe

Post a Product on Biotechnology Europe

Post a Publication on Biotechnology Europe

Post a Technology on Biotechnology Europe

Post a Resume on Biotechnology Europe

Terms of Business

Imprint

Privacy Policy

FAQ

Subscribe Newsletter

 

Helmholtz Zentrum München News

   

 

 

   
     

   
 
   
   
   
 
   
   
   
   
   
   
   
   
   
   
   
   
   

post your news I subscribe newsletter I contact us

 
 
   

 

 

Valuable Insights – Scientists of Helmholtz Zentrum München and the Technische Universität München Elucidate the Structural Details of a Key Protein for Cellular Signal Transduction

26 July 2010 Neuherberg, Germany

 

Scientists of the Institute of Structural Biology of Helmholtz Zentrum München and the Technische Universität München have succeeded in elucidating the structure of an important region of the Sam68 protein. The renowned Journal of Biological Chemistry has selected the report of these research findings as one of two “papers of the week” for its September 10, 2010 issue and has chosen the structural model as cover image.

 

Using NMR spectroscopy, Professor Michael Sattler and his team elucidated the spatial structure of the Qua1 region of Sam68, which is responsible for the dimerization of the protein. In collaboration with the research group of Professor Ruth Brack-Werner of the Institute of Virology, the authors showed that this region is essential for the biological function of Sam68. The image reveals an unusual spatial structure, in which two helices of respectively one Qua1 region (green and blue) interact with each other and mediate the dimerization of Qua1 and thus of Sam68.

 
 

Sam68 belongs to the family of STAR proteins which carry out important tasks in the signal-regulated processing of genetic information and its translation into protein. Among others, Sam68 regulates specific processes linked to the cell cycle and apoptosis and plays a key role in the pathogenesis of cancer. 

  Prostate Cancer Translational Research in Europe: the search for biomarkers continues

Cryosurgery: Primary treatment option for prostate cancer
 

Original publication:
Meyer, NH. et al.: Structural basis for homodimerization of the Src-associated during mitosis, 68 kD protein (Sam68) Qua1 domain. –The Journal of Biological Chemistry, Vol. 285, Issue 37, 28893-28901, 10. September 2010; www.jbc.org/content/early/2010/07/06/jbc.M110.126185.abstract

 
 More News from Helmholtz Zentrum München  I add this page to your favorites
 
26.07.2010 Important Clue to Understanding the Pathogenesis of Ciliary Disorders
Skeletal muscles combust both lipids and carbohydrates during exercise. The carbohydrates consist of both glycogen stored in the muscles as well as glucose extracted from the blood. Being a major sink for glucose disposal, skeletal muscle represents an important model tissue for studying the intracellular signaling pathways leading to increased glucose transport.

 

Helmholtz Zentrum München is the German Research Center for Environmental Health. Our aim is to develop an individualized medical approach to the prevention and treatment of widespread common diseases such as diabetes mellitus, lung diseases and diseases of the nervous system. As one of the world’s leading centers with a focus on Environmental Health, we investigate the interaction of genetic disposition, environmental factors and lifestyle. Helmholtz Zentrum München has approximately 1800 staff members; its head office is located in Neuherberg to the north of Munich on a 50-hectare research campus. Helmholtz Zentrum München belongs to the Helmholtz Association, Germany’s largest research organization, a community of 16 scientific-technical and medical-biological research centers with a total of 26,500 staff members. – www.helmholtz-muenchen.de

 

Technische Universitaet Muenchen (TUM) is one of Europe¹s leading universities. It has roughly 420 professors, 7,500 academic and non-academic staff (including those at the university hospital ³Rechts der Isar²), and 24,000 students. It focuses on the engineering sciences, natural sciences, life sciences, medicine, and economic sciences. After winning numerous awards, it was selected as an ³Elite University² in 2006 by the Science Council (Wissenschaftsrat) and the German Research Foundation (DFG). The university¹s global network includes an outpost in Singapore. TUM is dedicated to the ideal of a top-level research based entrepreneurial university.

 

Contact for Media Representatives

Sven Winkler, Helmholtz Zentrum München – German Research Center for Environmental Health, Ingolstädter Landstr. 1, 85764 Neuherberg, Germany - Phone: +49(0)89-3187-3946, Fax +49(0)89-3187-3324, Internet: www.helmholtz-muenchen.de, e-mail: presse@helmholtz-muenchen.de.

 

 

  More News I add this page to your favorites
New molecular signaling cascade increases glucose uptake
Skeletal muscles combust both lipids and carbohydrates during exercise. The carbohydrates consist of both glycogen stored in the muscles as well as glucose extracted from the blood. Being a major sink for glucose disposal, skeletal muscle represents an important model tissue for studying the intracellular signaling pathways leading to increased glucose transport.

 

 
Tinnitus – low heritability
The relative importance of genetic factors in tinnitus is low, according to new research from the Norwegian Institute of Public Health. This is the first large population-based study to measure the heritability of tinnitus. The study looked at prevalence of tinnitus and to what degree it is hereditary. Prevalence of tinnitus was 15.1 percent, which correlates well with findings from other countries.

 

 
Young men with HIV infection have coronary atherosclerotic plaques, MGH study
A Massachusetts General Hospital (MGH) study has found that relatively young men with longstanding HIV infection and minimal cardiac risk factors had significantly more coronary atherosclerotic plaques - some involving serious arterial blockage - than did uninfected men with similar cardiovascular risk. The investigation appearing in the January 2010 issue of the journal AIDS is the first to use CT angiography to identify coronary artery plaques in HIV-infected participants. "We were particularly surprised to find that several of the HIV patients - none of whom had symptoms of heart disease - had obstructive coronary artery disease, which was found in none of the controls," says Janet Lo, MD, of the Program in Nutritional Metabolism in the MGH Department of Medicine, who led the study. "It appears that both traditional and nontraditional risk factors are contributing to atherosclerotic disease in HIV-infected patients."

 

 
Findings linked to a key molecule active in GI inflammation
In the largest, most comprehensive genetic analysis of childhood-onset inflammatory bowel disease (IBD), an international research team has identified five new gene regions, including one involved in a biological pathway that helps drive the painful inflammation of the digestive tract that characterizes the disease. A research team led by Hakon Hakonarson, M.D., Ph.D., director of the Center for Applied Genomics at The Children's Hospital of Philadelphia, says that the findings advance the scientific understanding of how IBD develops. "This is an evolving story of discovering what genes tell us about the disease," said Robert N. Baldassano, M.D., a co-first author of the study and director of the Center for Pediatric Inflammatory Bowel Disease at Children's Hospital. "Pinpointing how specific genes act on biological pathways provides a basis for ultimately personalizing medicine to an individual's genetic profile."

 

 
Strong alkaline substances can damage teeth
It has long been known that acids can erode tooth enamel but a new Swedish study from the Sahlgrenska Academy at the University of Gothenburg, Sweden, shows that strong alkaline substances can damage teeth too - substances with high pH values can destroy parts of the organic content of the tooth, leaving the enamel more vulnerable. The study was carried out at the Department of Occupational and Environmental Medicine at the Sahlgrenska Academy and published in the Journal of Dentistry.

   

 

Phytochemicals in plant-based foods could help battle obesity, disease

The cheeseburger and French fries might look tempting, but eating a serving of broccoli or leafy greens first could help people battle metabolic processes that lead to obesity and heart disease, a new University of Florida study shows. Eating more plant-based foods, which are rich in substances...

   

 

A Novel Gene-Silencing Protein Offers New Possibilities for Treatment of Cancer and Genetic Disorders

A study published recently in the Proceedings of the National Academy of Science (PNAS) by a team of scientists headed by Professors Hélène Bierne and Pascale Cossart from the Pasteur Institute, in collaboration with colleagues form the CNRS and the French Agricultural Research Institute (INRA), identified a novel protein, BAHD1, which is responsible for changing DNA structure and silencing the expression of genes.

   
 
   
   
 I back I top I  
 

 
 
   

 

 

                                                                

                                       

                                         office@biotechnology-europe.com I website@biotechnology-europe.com I service@biotechnology-europe.com

 


 

Advertising Opportunities on Biotechnology Europe

Sponsorship Opportunities on Biotechnology Europe

About Biotechnology Europe

Post a Job on Biotechnology Europe

Post a Company Profile on Biotechnology Europe

Post a News on Biotechnology Europe

Post an Event on Biotechnology Europe

Post a Product on Biotechnology Europe

Post a Publication on Biotechnology Europe

Post a Technology on Biotechnology Europe

Post a Resume on Biotechnology Europe


 

Biotechnology Europe Your Partner in Bioscience and Business

  Central Internet Platform and Service Company For The Life Sciences in Europe

Imprint I Site map I Privacy Policy I Contact us I About us I Copyright BIOTECHNOLOGY WORLD  All rights reserved